Anna Tominaga

BMedSci (Hons), BSc
Project Officer, ASPREE

Phone: +61 3 990 30688

Anna Tominaga began working at the ASPREE Clinical Trial in February 2016 as a Project Officer in the Endpoint Team. Anna's first publication was in September 2016 as co-first author: Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airways disease – find it here or here.